- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BeBetter Med Inc (688759)
BeBetter Med Inc stock price live, this page displays SS 688759 stock exchange data. View the 688759 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the BeBetter Med Inc real time stock price chart below.
What Is the BeBetter Med Inc Stock Price Today?
The BeBetter Med Inc stock price today is 28.25.
What Is the Stock Symbol for BeBetter Med Inc?
The stock symbol for BeBetter Med Inc is "688759."
What Stock Exchange Does BeBetter Med Inc Trade On?
BeBetter Med Inc is listed and trades on the Shanghai stock exchange.
Is BeBetter Med Inc a Good Stock to Buy?
Determining whether BeBetter Med Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688759 quote. (ISIN: CNE100007CZ3)
What Is the BeBetter Med Inc Stock Price Today?
The BeBetter Med Inc stock price today is 28.25.
What Is the Stock Symbol for BeBetter Med Inc?
The stock symbol for BeBetter Med Inc is "688759."
What Stock Exchange Does BeBetter Med Inc Trade On?
BeBetter Med Inc is listed and trades on the Shanghai stock exchange.
Is BeBetter Med Inc a Good Stock to Buy?
Determining whether BeBetter Med Inc, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 688759 quote. (ISIN: CNE100007CZ3)
Shanghai
Currency in CNY
28.25
+1.34(+4.98%)
Closed·
Fair Value
An estimate of a BeBetter Med's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.67
29.14
52 wk Range
20.70
57.47
688759 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a BeBetter Med's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.6729.14
52 wk Range
20.7057.47
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
688759 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a BeBetter Med's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
50.22
Upside
+77.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 50.22
(+77.77% Upside)
Earnings
Latest Release
Apr 27, 2026
EPS / Forecast
-0.12 / --
Revenue / Forecast
-- / --
Compare 688759 to Peers and Sector
Metrics to compare | 688759 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688759PeersSector | |
|---|---|---|---|---|
P/E Ratio | −76.2x | 30.7x | −0.3x | |
PEG Ratio | - | 0.02 | 0.00 | |
Price/Book | 8.0x | 3.2x | 2.6x | |
Price / LTM Sales | - | 7.5x | 3.1x | |
Upside (Analyst Target) | 77.8% | 4.0% | 48.3% | |
Fair Value Upside | Unlock | 18.7% | 6.7% | Unlock |
BeBetter Med Inc., a biopharmaceutical company, engages in the research and development, and sale of drugs for oncology, metabolic diseases and central nervous system degenerative diseases. It offers BEBT-908, a PI3K/HDAC dual-target small molecule inhibitor for antitumor; developing BEBT-209, a CDK4/6 selective inhibitor for metastatic triple-negative breast cancer; and BEBT-109, a selective EGFR inhibitor designed for NSCLC. The company also develops BEBT-503, an oral, well-balanced pan-PPAR for metabolic diseases including diabetes and mash; BEBT-507, a GalNAc-siRNA drug for Polycythemia Vera (PV); and BEBT-701, a GalNAc-siRNA therapeutic for treatment of hypertension with co-existing hyperlipidemia. In addition, it provides BEBT-809, a small molecule inhibitor for obesity; BEBT-706, for ASCVD risk reduction; BEBT-720, for mash; BEBT-758, for the treatment of Parkinson's disease; BEBT-756, for Alzheimer's disease; BEBT-730, for hyperuricemia and gout; BEBT-733, for renal anemia/CKD; and BEBT-738, for diabetes. The company was founded in 2012 and is based in Guangzhou, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the BeBetter Med (688759) Stock Price Today?
The BeBetter Med stock price today is 28.25 CNY.
What Stock Exchange Does BeBetter Med Trade On?
BeBetter Med is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for BeBetter Med?
The stock symbol for BeBetter Med is "688759."
What Is the BeBetter Med Market Cap?
As of today, BeBetter Med market cap is 12.11B CNY.
What Is BeBetter Med's Earnings Per Share (TTM)?
The BeBetter Med EPS (TTM) is -0.42.
From a Technical Analysis Perspective, Is 688759 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has BeBetter Med Stock Split?
BeBetter Med has split 0 times.
How Many Employees Does BeBetter Med Have?
BeBetter Med has 160 employees.
What is the current trading status of BeBetter Med (688759)?
As of Aug 13, 2026, BeBetter Med (688759) is trading at a price of 28.25 CNY, with a previous close of 26.91 CNY. The stock has fluctuated within a day range of 26.67 CNY to 29.14 CNY, while its 52-week range spans from 20.70 CNY to 57.47 CNY.
What Is BeBetter Med (688759) Price Target According to Analysts?
The average 12-month price target for BeBetter Med is 50.22 CNY, with a high estimate of 50.22 CNY and a low estimate of 50.22 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +77.77% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.